C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2001
11/01/2001	WO2001081908A1 Field effect transistor device for ultra-fast nucleic acid sequencing
11/01/2001	WO2001081906A1 Denaturant-free electrophoresis of biological molecules under high temperature conditions
11/01/2001	WO2001081896A1 An ultra-fast nucleic acid sequencing device and a method for making and using the same
11/01/2001	WO2001081634A2 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
11/01/2001	WO2001081633A1 Association of protein kinase c zeta polymorphisms with diabetes
11/01/2001	WO2001081632A1 Methods for monitoring the expression of alternatively spliced genes
11/01/2001	WO2001081631A1 Detection of nucleotide sequence variations via the proofreading activity of polymerases
11/01/2001	WO2001081629A1 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
11/01/2001	WO2001081628A1 Nucleic acid sequences associated with baldness
11/01/2001	WO2001081627A2 N-silico-screening for docking on sub-domain iiid of hcv-ires
11/01/2001	WO2001081626A2 Methods for clinical diagnosis
11/01/2001	WO2001081625A1 Method for quantitative measurement of gene expression
11/01/2001	WO2001081624A1 Method for mutation detection in hiv using pol sequencing
11/01/2001	WO2001081623A2 Neuronally expressed protein having apoptotic activity, and use thereof
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081621A2 Method, diagnostic kit and microarray for determining the rhesus factor
11/01/2001	WO2001081620A2 Method for the highly parallel analysis of polymorphisms
11/01/2001	WO2001081618A1 Method of measuring biological luminescence
11/01/2001	WO2001081617A1 Method of determining amylase concentrations
11/01/2001	WO2001081616A2 Method for screening of microorganisms under nutrient limited conditions
11/01/2001	WO2001081615A1 Composition and method for detecting and early and differentiated counting of gram-negative microorganisms
11/01/2001	WO2001081614A2 Cell proliferation assay
11/01/2001	WO2001081613A2 Method for the identification of active site protease inactivators
11/01/2001	WO2001081608A2 Viral vectors for use in monitoring hiv drug resistance
11/01/2001	WO2001081603A2 Trophic conversion of obligate phototrophic algae through metabolic engineering
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081587A1 Acetyltransferase and uses thereof
11/01/2001	WO2001081586A2 21657, a human short-chain dehydrogenase and uses thereof
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081575A1 Primer for diagnosis of one or more kinds of cancer
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081557A2 Human kinase proteins and polynucleotides encoding the same
11/01/2001	WO2001081549A2 Hepatocyte lineage cells derived from pluripotent stem cells
11/01/2001	WO2001081548A1 Novel cell systems having specific interaction of peptide binding pairs
11/01/2001	WO2001081547A2 Identification, cloning and characterization of a novel pc-1 gene differentially expressed in prostate cells and tissues
11/01/2001	WO2001081543A2 Multilocus repetitive dna sequences for genotyping bacillus anthracis and related bacteria
11/01/2001	WO2001081542A2 Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data
11/01/2001	WO2001081541A2 Pcr-hybridization assays specific for integrated retroviruses
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081446A1 Electroactive complex, electroactive probe and preparation method
11/01/2001	WO2001081429A1 Differential microbial test
11/01/2001	WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	WO2001081409A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
11/01/2001	WO2001081400A1 Nk-2 homeobox transcription factor
11/01/2001	WO2001081375A2 Dna & protein binding miniature proteins
11/01/2001	WO2001081362A1 Method of detecting carcinomas
11/01/2001	WO2001081351A1 Fluorescent compounds
11/01/2001	WO2001080964A1 Mipc chromatographic apparatus with improved temperature control
11/01/2001	WO2001080903A1 Detection and treatment of atherosclerosis based on plasma sphingomyelin concentration
11/01/2001	WO2001080876A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080872A1 Method of binding integrin for treatment of cancer
11/01/2001	WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001	WO2001080722A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080721A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080720A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080719A2 Methods and composition for the diagnosis of schizophrenia
11/01/2001	WO2001080718A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080717A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080716A2 Methods and compositions for the diagnosis of schizophrenia
11/01/2001	WO2001080712A2 Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease
11/01/2001	WO2001080711A2 Method of evaluating a risk of a subject of developing vascular complications
11/01/2001	WO2001080663A1 Animal feed additives and method of producing the same
11/01/2001	WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv
11/01/2001	WO2001080626A1 Nucleic acids that control plant development
11/01/2001	WO2001068834B1 Nucleotide detector, process for producing the same and process for forming fine particle membrane
11/01/2001	WO2001036976A3 Novel diagnosis and treatment for atherosclerosis
11/01/2001	WO2001036939A3 Method for the automatic analysis of microscope images
11/01/2001	WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001034832A3 Assays using redox-enzymes immobilised n hydrophilic polymers
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001034634A8 Tumor suppressor molecules and methods of use
11/01/2001	WO2001032933B1 Assay method for determining product r's effect on induction of ifn-gamma in cultured cells
11/01/2001	WO2001028500A3 Uses of antileukoprotease in carcinoma
11/01/2001	WO2001025474A3 Sensor for measuring a bioanalyte such as lactate
11/01/2001	WO2001023611A3 Methods for detecting amplification by change of fluorescence
11/01/2001	WO2001022864A3 Sequences characteristic of bladder cancer
11/01/2001	WO2001020030A3 Nucleotide sequences derived from genes coding for trimethylamine n-oxide reductase, uses thereof in particular for detecting bacteria
11/01/2001	WO2001016374A3 Methods and reagents for in situ amplification
11/01/2001	WO2001016367A8 Methods for exogenous, internal controls during nucleic acid amplification
11/01/2001	WO2001016363A3 Rapid, highly specific detection method for pseudomonas aeruginosa using multi-probe detection
11/01/2001	WO2001009176A3 Mammalian cytokines; related reagents
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000062931A9 The use of microfluidic systems in the electrochemical detection of target analytes
11/01/2001	WO2000059918A9 EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
11/01/2001	WO2000050632A9 Polymorphic dna fragments and uses thereof
11/01/2001	WO2000047775A9 Selection of proteins using rna-protein fusions
11/01/2001	WO2000047764A3 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
11/01/2001	WO2000040607A3 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
11/01/2001	WO2000039342A9 Use of essential saccharomyces genes and polypeptides
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	US20010036955 Method of inhibiting angiogenesis
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists

1 ... 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 ... 3003